Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005730 | nucleolus | 5 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043228 | non-membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: Q4QIX4
Term | Name | Level | Count |
---|---|---|---|
GO:0044087 | regulation of cellular component biogenesis | 4 | 2 |
GO:0050789 | regulation of biological process | 2 | 2 |
GO:0050794 | regulation of cellular process | 3 | 2 |
GO:0065007 | biological regulation | 1 | 2 |
GO:0090069 | regulation of ribosome biogenesis | 5 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 12 |
GO:0005488 | binding | 1 | 12 |
GO:0097159 | organic cyclic compound binding | 2 | 12 |
GO:1901363 | heterocyclic compound binding | 2 | 12 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 162 | 166 | PF00656 | 0.654 |
CLV_C14_Caspase3-7 | 47 | 51 | PF00656 | 0.407 |
CLV_NRD_NRD_1 | 122 | 124 | PF00675 | 0.564 |
CLV_NRD_NRD_1 | 155 | 157 | PF00675 | 0.611 |
CLV_NRD_NRD_1 | 47 | 49 | PF00675 | 0.289 |
CLV_PCSK_KEX2_1 | 122 | 124 | PF00082 | 0.448 |
CLV_PCSK_KEX2_1 | 142 | 144 | PF00082 | 0.564 |
CLV_PCSK_KEX2_1 | 153 | 155 | PF00082 | 0.504 |
CLV_PCSK_PC1ET2_1 | 142 | 144 | PF00082 | 0.564 |
CLV_PCSK_PC1ET2_1 | 153 | 155 | PF00082 | 0.504 |
CLV_PCSK_SKI1_1 | 123 | 127 | PF00082 | 0.488 |
CLV_PCSK_SKI1_1 | 19 | 23 | PF00082 | 0.319 |
DEG_Kelch_Keap1_1 | 157 | 162 | PF01344 | 0.518 |
DOC_CYCLIN_RxL_1 | 15 | 25 | PF00134 | 0.417 |
DOC_CYCLIN_yCln2_LP_2 | 181 | 187 | PF00134 | 0.563 |
DOC_MAPK_gen_1 | 45 | 55 | PF00069 | 0.291 |
DOC_MAPK_MEF2A_6 | 182 | 189 | PF00069 | 0.565 |
DOC_USP7_MATH_1 | 96 | 100 | PF00917 | 0.696 |
DOC_USP7_UBL2_3 | 15 | 19 | PF12436 | 0.465 |
DOC_USP7_UBL2_3 | 195 | 199 | PF12436 | 0.661 |
DOC_USP7_UBL2_3 | 45 | 49 | PF12436 | 0.302 |
DOC_WW_Pin1_4 | 180 | 185 | PF00397 | 0.514 |
DOC_WW_Pin1_4 | 203 | 208 | PF00397 | 0.661 |
DOC_WW_Pin1_4 | 223 | 228 | PF00397 | 0.547 |
DOC_WW_Pin1_4 | 94 | 99 | PF00397 | 0.670 |
LIG_14-3-3_CanoR_1 | 78 | 87 | PF00244 | 0.523 |
LIG_14-3-3_CanoR_1 | 9 | 17 | PF00244 | 0.456 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.556 |
LIG_BRCT_BRCA1_1 | 68 | 72 | PF00533 | 0.415 |
LIG_deltaCOP1_diTrp_1 | 63 | 72 | PF00928 | 0.466 |
LIG_FHA_1 | 126 | 132 | PF00498 | 0.480 |
LIG_FHA_1 | 224 | 230 | PF00498 | 0.574 |
LIG_FHA_1 | 65 | 71 | PF00498 | 0.461 |
LIG_FHA_1 | 82 | 88 | PF00498 | 0.503 |
LIG_FHA_2 | 102 | 108 | PF00498 | 0.631 |
LIG_FHA_2 | 192 | 198 | PF00498 | 0.607 |
LIG_FHA_2 | 199 | 205 | PF00498 | 0.591 |
LIG_FHA_2 | 45 | 51 | PF00498 | 0.400 |
LIG_LIR_Gen_1 | 69 | 79 | PF02991 | 0.405 |
LIG_LIR_Nem_3 | 114 | 120 | PF02991 | 0.623 |
LIG_LIR_Nem_3 | 69 | 75 | PF02991 | 0.440 |
LIG_PDZ_Class_2 | 225 | 230 | PF00595 | 0.620 |
LIG_SH3_1 | 215 | 221 | PF00018 | 0.491 |
LIG_SH3_3 | 215 | 221 | PF00018 | 0.487 |
LIG_SUMO_SIM_par_1 | 208 | 214 | PF11976 | 0.553 |
LIG_UBA3_1 | 186 | 195 | PF00899 | 0.502 |
LIG_UBA3_1 | 210 | 215 | PF00899 | 0.479 |
MOD_CK1_1 | 136 | 142 | PF00069 | 0.499 |
MOD_CK1_1 | 172 | 178 | PF00069 | 0.729 |
MOD_CK1_1 | 25 | 31 | PF00069 | 0.362 |
MOD_CK1_1 | 97 | 103 | PF00069 | 0.664 |
MOD_CK2_1 | 101 | 107 | PF00069 | 0.774 |
MOD_CK2_1 | 191 | 197 | PF00069 | 0.677 |
MOD_CK2_1 | 8 | 14 | PF00069 | 0.522 |
MOD_GlcNHglycan | 135 | 138 | PF01048 | 0.564 |
MOD_GlcNHglycan | 148 | 151 | PF01048 | 0.545 |
MOD_GlcNHglycan | 159 | 162 | PF01048 | 0.657 |
MOD_GlcNHglycan | 176 | 179 | PF01048 | 0.723 |
MOD_GlcNHglycan | 24 | 27 | PF01048 | 0.346 |
MOD_GSK3_1 | 169 | 176 | PF00069 | 0.634 |
MOD_GSK3_1 | 81 | 88 | PF00069 | 0.565 |
MOD_GSK3_1 | 94 | 101 | PF00069 | 0.605 |
MOD_N-GLC_1 | 169 | 174 | PF02516 | 0.729 |
MOD_N-GLC_1 | 5 | 10 | PF02516 | 0.472 |
MOD_NEK2_1 | 190 | 195 | PF00069 | 0.532 |
MOD_NEK2_1 | 22 | 27 | PF00069 | 0.314 |
MOD_PIKK_1 | 169 | 175 | PF00454 | 0.626 |
MOD_PIKK_1 | 64 | 70 | PF00454 | 0.492 |
MOD_PKA_2 | 191 | 197 | PF00069 | 0.651 |
MOD_PKA_2 | 8 | 14 | PF00069 | 0.522 |
MOD_ProDKin_1 | 180 | 186 | PF00069 | 0.507 |
MOD_ProDKin_1 | 203 | 209 | PF00069 | 0.660 |
MOD_ProDKin_1 | 223 | 229 | PF00069 | 0.550 |
MOD_ProDKin_1 | 94 | 100 | PF00069 | 0.672 |
MOD_SUMO_for_1 | 126 | 129 | PF00179 | 0.489 |
MOD_SUMO_rev_2 | 101 | 111 | PF00179 | 0.574 |
MOD_SUMO_rev_2 | 136 | 144 | PF00179 | 0.549 |
MOD_SUMO_rev_2 | 193 | 201 | PF00179 | 0.679 |
TRG_DiLeu_BaLyEn_6 | 181 | 186 | PF01217 | 0.500 |
TRG_ER_diArg_1 | 154 | 156 | PF00400 | 0.697 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5L2 | Leptomonas seymouri | 67% | 89% |
A0A0S4JRZ3 | Bodo saltans | 44% | 100% |
A0A1X0NMG7 | Trypanosomatidae | 42% | 95% |
A0A3R7RBC9 | Trypanosoma rangeli | 53% | 100% |
A0A3S7WPL1 | Leishmania donovani | 94% | 100% |
A4H4R5 | Leishmania braziliensis | 80% | 100% |
A4HSZ4 | Leishmania infantum | 94% | 100% |
C9ZTM6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 85% |
E9AKY1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
V5BNM6 | Trypanosoma cruzi | 51% | 100% |